Clarisonic Pore And Blemish Cleanser Acne Treatment
NDC Package 69481-333-01

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Clarisonic Pore And Blemish Cleanser Acne Treatment is a . Marketed by Pacific Bioscience Laboratories, Inc., this product is identified by NDC 69481-333 and is authorized under FDA application M006.

Identification & Billing

NDC Package Code
69481-333-01
Package Description
120 mL in 1 TUBE
Product Code
69481-333
11-Digit Billing Format
69481033301

Clinical Specifications

Proprietary Name
Clarisonic Pore And Blemish Cleanser Acne Treatment
Dosage Form
-

Regulatory & Marketing

Labeler Name
Pacific Bioscience Laboratories, Inc.
FDA Application #
M006
Marketing Category
OTC MONOGRAPH DRUG -
Start Marketing Date
08-10-2017
End Marketing Date
06-10-2024
Listing Expiration
06-10-2024
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69481-333-01 identifies a specific commercial package of 120 ml in 1 tube of Clarisonic Pore And Blemish Cleanser Acne Treatment, labeled by Pacific Bioscience Laboratories, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Pacific Bioscience Laboratories, Inc. on August 10, 2017. The current certification is valid through June 10, 2024.

How is this Pacific Bioscience Laboratories, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69481033301. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
69481-333-01
11-Digit CMS (5-4-2)
69481-0333-01

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.